© 2018 Neuroplast  • All rights reserved  • Design by Brightlands Maastricht Health Campus

PRESS RELEASE, 18 February 2020

Neuroplast raises € 4 million for its stem cell-based technology to treat patients with Spinal Cord Injury. 

Read more

PRESS RELEASE, 01 May 2019

European Medicines Agency (EMA) has granted Orphan Drug Designation to Neuroplast treatment. 

Read more